Section 369-DD. Analysis of pharmaceutical expenditures and patterns in relation to medicaid managed care

1. The drug utilization review  board
  shall   analyze   and   compare   expenditures,  utilization  rates  and
  utilization patterns for pharmaceutical services (along with any related
  effects on expenditures, rates and  patterns  for  other  services)  for
  medical assistance recipients:
    (a)  for  the period during which medical assistance reimbursement for
  such services was included in the state rate  of  payment  for  medicaid
  managed care; and
    (b) for the period beginning with the date on which medical assistance
  reimbursement for such services was no longer included in the state rate
  of payment for medicaid managed care.
    2.  The  board  shall  include  in  its  analyses and comparisons, the
  expenditures,   utilization   rates   and   utilization   patterns   for
  pharmaceutical services (along with any related effects on expenditures,
  rates  and  patterns for other services) paid for by private third-party
  payors.
    3. The board shall report its findings to the governor, the  temporary
  president  of  the  senate  and  the speaker of the assembly by December
  first, nineteen hundred ninety-nine.
    * NB Repealed March 31, 2012